Skip to Main Content

Author Details

Michel Marre
1979
455
78
PMIDPaper TitleJournal TitlePublished Year
36822744Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control study.2023
36053971Associations of microvascular complications with all-cause death in patients with diabetes and COVID-19: The CORONADO, ABCD COVID-19 UK national audit and AMERICADO study groups.Diabetes, Obesity and Metabolism2023
37802242Facing the evidences with type 2 diabetes: Contemporary challenges.2023
37978231Genetic variants of interferon-response factor 5 are associated with the incidence of chronic kidney disease: the D.E.S.I.R. study.2023
37709961Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity.Nat Metab2023
38051360Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.2023
34853028Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes.Diabetes Care2022
35583678Plasma Adrenomedullin, Allelic Variations in the ADM Gene, and Risk for Lower-Limb Amputation in People With Type 2 Diabetes.Diabetes Care2022
35896277Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality: Results from a Randomized Controlled Trial of ACE Inhibitors.Clin J Am Soc Nephrol2022
36221106Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes.Cardiovascular Diabetology2022
35439582Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE.Int J Cardiol2022
36331712Initiation of the Fixed Combination IDegLira in Patients with Type 2 Diabetes on Prior Injectable Therapy: Insights from the EASY French Real-World Study.Diabetes Therapy2022
35534880Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes.Cardiovascular Diabetology2022
36552894Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes.2022
34580995Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP-1RA treatment: A subgroup analysis from the FIDELIO-DKD trial.Diabetes Obes Metab2022
34448881Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.Diabetologia2021
33539672The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65â¿¿years: Results from the ADVANCE trial.Diabetes Obes Metab2021
34226943Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.Diabetologia2021
33577905Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study.Diabetes Research and Clinical Practice2021
33883461Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials.J Hypertens2021
33827803I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes.Diabetes Care2021
34035077The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial.Diabetes Care2021
33606920Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial.Diabetes Obes Metab2021
34085949Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO study.European Journal of Endocrinology2021
33309936Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.2021
33141880Plasma total adiponectin and changes in renal function in a cohort from the community: the prospective Data from an Epidemiological Study on the Insulin Resistance Syndrome study.Nephrology Dialysis Transplantation2021
33242514Monogenic diabetes characteristics in a transnational multicenter study from Mediterranean countries.Diabetes Research and Clinical Practice2021
33409569Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study.Diabetologia2021
33397352History of lower-limb complications and risk of cancer death in people with type 2 diabetes.Cardiovascular Diabetology2021
31388097The expression of genes in top obesity-associated loci is enriched in insula and substantia nigra brain regions involved in addiction and reward.International Journal of Obesity2020
32259661Relationship between renal capacity to reabsorb glucose and renal status in patients with diabetes.2020
32250521Importance of intensive blood pressure control in type 2 diabetes: Mechanisms, treatments and current guidelines.Diabetes, Obesity and Metabolism2020
32393479Comparison of a new versus standard removable offloading device in patients with neuropathic diabetic foot ulcers: a French national, multicentre, open-label randomized, controlled trial.BMJ Open Diabetes Research and Care2020
31988064Leukocyte Telomere Length, DNA Oxidation, and Risk of Lower-Extremity Amputation in Patients With Long-standing Type 1 Diabetes.Diabetes Care2020
32447101Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports.2020
31806652Plasma Apelin and Risk of Type 2 Diabetes in a Cohort From the Community.Diabetes Care2020
33046911Pathogenic variants in actionable MODY genes are associated with type 2 diabetes.Nat Metab2020
33115821Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events.BMJ Open Diabetes Research and Care2020
33055101Relationship Between Diabetic Retinopathy Stages and Risk of Major Lower-Extremity Arterial Disease in Patients With Type 2 Diabetes.Diabetes Care2020
32609422Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.J Diabetes2020
31539622Efficacy and safety of once-weekly semaglutide 1.0mg vs once-daily liraglutide 1.2mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10).2020
31486188Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial.Diabetes Obes Metab2020
31537649Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.J Am Soc Nephrol2019
31700171Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension.Nature Medicine2019
31582427Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes.Diabetes Care2019
31668389New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans.Mol Metab2019
29982607Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patients.Nephrology Dialysis Transplantation2019
30455333Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.Diabetes Care2019
30487263Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control.Diabetes2019
30571562Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.Hypertension2019
  • 1 - 50 of 455

Recommended Authors

Collaborators

Co-authored papers 104
Co-authored papers 95
Co-authored papers 72
Co-authored papers 57
Co-authored papers 49
Co-authored papers 38
Institute of Cardiovascular Sciences, University College London.
Co-authored papers 32
Montreal University Hospital Research Center
Co-authored papers 30
Co-authored papers 28
Co-authored papers 28
Co-authored papers 20
Co-authored papers 17
Co-authored papers 17
Co-authored papers 16
Co-authored papers 15
Co-authored papers 15
Co-authored papers 15
Folkhalsan Institute of Genetics, Folkhalsan Research Center
Co-authored papers 14
Co-authored papers 14
Co-authored papers 14
Co-authored papers 14
Co-authored papers 13
Co-authored papers 13
Co-authored papers 13
Co-authored papers 13
Co-authored papers 12
Folkhalsan Institute of Genetics, Folkhalsan Research Center
Co-authored papers 12
Co-authored papers 11
Co-authored papers 10
Co-authored papers 10